Target intelligence / Profile preview

Ribosomal protein S12 pseudogene 20 (RPS12P20)

Target
RPS12P20
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein S12 pseudogene 20 (RPS12P20) is a processed human pseudogene derived from the ribosomal protein S12 gene (RPS12)[2][6]. Unlike the parental protein-coding RPS12 gene, RPS12P20 does not encode a functional protein and is classified as a pseudogene. Pseudogenes are usually non-functional genetic sequences that arise from duplication or retrotransposition of a functional gene, and typically do not produce stable or functional proteins due to mutations or lack of necessary regulatory sequence elements[6]. There is no evidence that RPS12P20 functions as a protein, a therapeutic target, or has disease involvement. It is typically listed in gene catalogues for completeness but has no known direct biological or clinical significance. Special notes regarding accuracy: - RPS12P20 is not a protein-coding gene and not a therapeutic target. It is a pseudogene, meaning it does not encode a functional protein and is not druggable or relevant for biomarker development or therapy[2][6]. - Other related entries (such as RPS12) refer to legitimate ribosomal proteins, but the pseudogene forms (including RPS12P20) are generally not biologically active[1][6]. - Therefore, is_incorrect: True because this entity does not fit definitions for a valid therapeutic target or receptor.

Other names
RPS12_10_1153RPS12P20
02

Mechanism of action

None

03

Biological functions

None (pseudogenes are generally non-coding and do not execute biological functions of their parental gene)[6].
04

Disease associations

None (No evidence of direct disease association; see description for context)[6].

Beyond the preview

Go deeper on Ribosomal protein S12 pseudogene 20 (RPS12P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S12 pseudogene 20 (RPS12P20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call